HE
SEC Insider//CIK 0001678292
Holuka Eugene Myron
CIK 00016782922 companiesCRANFORD, NJ
Transactions
18
Companies
2
Filings
16
CIK
0001678292
Recent Transactions
- Award
- Award
- Award
- Award
Stock Option (Right to Purchase Common Stock)
2024-11-07+125,000→ 125,000 total - Award
- Tax Payment
- Exercise/Conversion
Stock Option (Right to Purchase Common Stock)
2024-03-13−2,415→ 0 total - Exercise/Conversion
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
- Award
Options to Purchase Common Stock
2016-06-23$0.80/sh+200,000→ 200,000 total
Companies
2Recent Filings
16- 4/A
Holuka Eugene Myron
Dec 22, 2025
- 4
Holuka Eugene Myron
Sep 23, 2025
- 4
Holuka Eugene Myron
Dec 16, 2024
- 4
Holuka Eugene Myron
Nov 12, 2024
- 4
Holuka Eugene Myron
Aug 30, 2024
- 4
Holuka Eugene Myron
Aug 16, 2024
- 4
Holuka Eugene Myron
Oct 12, 2023
- 4
Holuka Eugene Myron
Oct 6, 2022
- 4
Holuka Eugene Myron
Oct 13, 2021
- 4
Holuka Eugene Myron
Jul 26, 2021
- 4
Holuka Eugene Myron
Feb 18, 2021
- 4
Holuka Eugene Myron
Oct 9, 2020
- 4
Holuka Eugene Myron
Jul 9, 2020
- 4
Holuka Eugene Myron
Oct 10, 2019
- 4
Holuka Eugene Myron
Sep 6, 2018
- 4
Citius Pharmaceuticals, Inc.
Jun 29, 2016
Address
C/O CITIUS ONCOLOGY, INC. 11 COMMERCE DRIVE, 1ST FLOOR
CRANFORD, NJ, 07016